Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Which Altcoins Have Real World Use Cases discusses projects with verifiable deployments and realistic paths to adoption and value.
28,091 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
SpaceX is counting down to a defining moment within two weeks. This guide explains what the milestone could mean for ...
Meta Platforms Just Gave A Massive Warning To AI Infra. As Meta pivots toward renting excess cloud capacity, small ne...
A strong quarter from TSMC is more than a one-off beat. This analysis explains why tsmc's revenue grew last and how c...
In 2025, rare earths drew intense attention as prices and equities raced higher. The rally cooled quickly, leaving in...
Insider moves always spark questions. This article unpacks EverCommerce's sells 19,200 shares, what it signals, and h...
When a fintech stock investor trims a large stake in a rising Brazilian payments firm, traders and everyday investors...
Meta Platforms has cooled off from its peak even as its AI initiatives accelerate. This article breaks down what to e...
A new alliance led by the linux foundation and tech giants forms Akrites, a security backbone for open-source project...
Sandisk stock just jumped, and investors want to know why. This article breaks down the key catalysts behind the move...
On a day when markets slid on inflation fears, one small-cap stock surprised investors by rocketing higher. Here’s wh...
A sudden loss on a very public day underscores the importance of financial planning. This article uses the story of t...